| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Pulmonary Dept, Internal Medicine, University Hospital Mainz, Mainz, Germany
CORRESPONDENCE: K.M. Beeh, Pulmonary Dept, Internal Medicine, University Hospital, Langenbeckstr. 1, 55131, Mainz, Germany. Fax: 49 161311175661. E-mail: k.beeh@3-med.klinik.uni-mainz.de
Keywords: antioxidants, glutathione, induced sputum, pulmonary fibrosis
Received: July 19, 2001
Accepted February 10, 2002
Idiopathic pulmonary fibrosis (IPF) is a disease of unknown aetiology. Increased oxidant burden and antioxidant, e.g. glutathione (GSH), deficiency in the lower respiratory tract have been thought to play a role in the progression of IPF. Sputum induction is a safe noninvasive tool to study inflammation in the respiratory tract.
The aim of the present study was to evaluate the direct measurement of GSH in induced sputum supernatant. Sixteen IPF patients and 15 healthy, nonsmoking subjects underwent sputum induction. Total GSH in sputum, saliva and plasma was measured spectrophotometrically.
Sputum GSH was decreased more then four-fold in IPF patients when compared to healthy subjects (mean GSH 1.4±0.34 µM versus 5.8±0.98 µM). Salivary GSH was generally low or undetectable in all subjects. Plasma GSH levels were lower in IPF patients (0.26±0.1 versus 0.74±0.16 µM). In IPF patients, there was a borderline correlation of sputum GSH levels with disease duration and lung-function impairment.
These data confirm the established role of oxidant/antioxidant imbalance in the pathogenesis of idiopathic pulmonary fibrosis, and show the potential of induced sputum to directly study inflammatory processes and surrogate markers in interstitial lung diseases like idiopathic pulmonary fibrosis.
This article has been cited by other articles:
|
|
 |
|
  P. Rogliani, M. Mura, M. Assunta Porretta, and C. Saltini Review: New perspectives in the treatment of idiopathic pulmonary fibrosis Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 75 - 93. [Abstract] [PDF]
|
|
|
|
 |
|
 I. Romieu, F. Castro-Giner, N. Kunzli, and J. Sunyer Air pollution, oxidative stress and dietary supplementation: a review Eur. Respir. J., January 1, 2008; 31(1): 179 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ramirez, B. Ramadan, J. D. Ritzenthaler, H. N. Rivera, D. P. Jones, and J. Roman Extracellular cysteine/cystine redox potential controls lung fibroblast proliferation and matrix expression through upregulation of transforming growth factor-beta Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L972 - L981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Y. Yeh, E. L. Burnham, M. Moss, and L. A. S. Brown Chronic Alcoholism Alters Systemic and Pulmonary Glutathione Redox Status Am. J. Respir. Crit. Care Med., August 1, 2007; 176(3): 270 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Rahman and I. M. Adcock Oxidative stress and redox regulation of lung inflammation in COPD. Eur. Respir. J., July 1, 2006; 28(1): 219 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Beeh, J. Beier, N. Koppenhoefer, and R. Buhl Increased Glutathione Disulfide and Nitrosothiols in Sputum Supernatant of Patients With Stable COPD Chest, October 1, 2004; 126(4): 1116 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Corradi, G. Folesani, R. Andreoli, P. Manini, A. Bodini, G. Piacentini, S. Carraro, S. Zanconato, and E. Baraldi Aldehydes and Glutathione in Exhaled Breath Condensate of Children with Asthma Exacerbation Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 395 - 399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. El-Chemaly, M. Salathe, S. Baier, G. E. Conner, and R. Forteza Hydrogen Peroxide-Scavenging Properties of Normal Human Airway Secretions Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 425 - 430. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
